Comparison of the effect of 5% minoxidil and topical epinephrine on the prevention of chemotherapy-induced hair loss in patients with breast cancer compared to the control group (placebo recipients) in 1398-1399
Phase 3
Recruiting
- Conditions
- Chemotherapy-induced hair loss.
- Registration Number
- IRCT20200205046380N1
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 63
Inclusion Criteria
Patients with breast cancer referred to Shohadaye Tajrish Hospital for chemotherapy including adriamycin, cyclophosphamide, and taxol in 2020-2021
Informed consent to participate in the study
Exclusion Criteria
Presence of metastasis
Presence of inflammatory scalp diseases
Patients with other causes of hair loss including telogen effluvium, lichen planopilaris, and discoid lupus erythematosus
Pregnant or lactating women
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The evaluation of anagen hair count in trichoscopic findings of patients. Timepoint: The first time, the second or third time, the last time and one month after chemotherapy. Method of measurement: FotoFinder device.
- Secondary Outcome Measures
Name Time Method